• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
PPIase Services

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
Registration Studies Using 14C

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

Upcoming Events

24 April 2017 to 26 April 2017
Selcia’s Director of Discovery will speak at the CHI Drug Discovery Chemistry Conference at the Sheraton Hotel & Marina, San Diego, CA.
4 May 2017 to 5 May 2017
12th Annual Great Lakes Drug Metabolism Meeting, Western Michigan University, Kalamazoo.

Selcia Tweets